9
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0155 |
Miglustat hydrochloride
NB-DNJ hydrochloride,盐酸美格鲁特,N-Butyldeoxynojirimycin hydrochloride,OGT918 hydrochloride |
Transferase | Metabolism |
Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) 是一种葡萄糖神经酰胺合酶抑制剂,可用于 I 型戈谢病的相关研究。 | |||
T35626 |
AMP-Deoxynojirimycin
AMP-DNM |
Transferase; Glucosidase | Metabolism |
AMP-Deoxynojirimycin (AMP-DNM) 是一种有效的神经酰胺葡萄糖基转移酶和 GCase 2 抑制剂。AMP-Deoxynojirimycin 是一种有效的 GlcCer 生物合成抑制剂,可用于研究帕金森和糖尿病。 | |||
T4473 |
Ibiglustat
Venglustat,SAR402671,GZ402671 |
Transferase | Metabolism |
Ibiglustat (GZ402671) 是一种可透过血脑屏障的、具有口服活性的葡萄糖神经酰胺合成酶(GCS)抑制剂。它可用于戈谢病 3 型、法布瑞氏症、与 GBA 突变相关的帕金森病、GM2 神经节苷脂病和常染色体显性多囊肾病的研究。 | |||
T70347 |
Ibiglustat hydrochloride
|
||
Ibiglustat hydrochloride is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. | |||
T36319 |
C6 L-erythro Ceramide (d18:1/6:0)
C6 L-erythro Ceramide (d18:1/6:0) |
||
C6 L-erythro Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. It is metabolized by ceramide glucosyltransferase to form C6 L-erythro glucosylceramide. C6 L-erythro Ceramide is cytotoxic to U937 cells (IC50 = 18 μM). | |||
T38489 | D,L-erythro-PDMP | ||
D,L-erythro-PDMP, an erythro isomer of PDMP, exhibits growth inhibition on cultured rabbit skin fibroblasts. Additionally, this compound serves as an effective inhibitor of UDP-glucose: ceramide glucosyltransferase. | |||
T36320 |
C6 L-threo Ceramide (d18:1/6:0)
C6 L-threo Ceramide (d18:1/6:0) |
||
C6 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 L-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). It is metabolically inactive and, unlike C6 L-erythro ceramide , C6 L-threo ceramide cannot be converted to C6 glucosylceramide by ceramide glucosyltransferase. C6 L-threo Ceramide enhances IL-4 production induced by phorbol 12-myristate 13-acetate in EL4 T cells when used at a concentration of 10 μM. | |||
T37565 |
C6 D-threo Ceramide (d18:1/6:0)
C6 D-threo Ceramide (d18:1/6:0) |
||
C6 D-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 D-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). It is metabolically inactive and, unlike C6 L-erythro ceramide , C6 D-threo ceramide cannot be converted to C6 glucosylceramide by ceramide glucosyltransferase. C6 D-threo Ceramide promotes survival of isolated rat spinal neurons when used at concentrations up to 2.5 μM but induces cell death at concentrations greater... | |||
T70336 |
Nizubaglustat
|
||
Nizubaglustat为一种针对神经酰胺葡萄糖基转移酶或葡萄糖神经酰胺合酶(GCS)的抑制剂,同时也能抑制GBA2,后者与神经病理学溶酶体贮积症相关。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12039 |
Miglustat
N-Butyldeoxynojirimycin,OGT918,美格鲁特,NB-DNJ,N-丙基脱氧野尻霉素 |
Others | Others |
Miglustat (NB-DNJ) 是一种葡萄糖神经酰胺合成酶抑制剂,可用于I 型戈谢病。 |